Public annual accounts

CompleMed Group financials

Name: CompleMed Group financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for CompleMed Group, with comparable measures and links to available source documents.

Company overview

Registry number

0886401044

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for CompleMed Group

2025 versus 2024

Operating line: €81,705
EBITDA: €31,406
Total assets: €43,463
Equity: -€11,149

EBITDA margin +38.4% · Equity ratio -25.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€81,705	€31,406	€43,463	-€11,149	-
202431 Dec 2024	€59,889	€11,825	€40,346	-€45,942	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report